Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
2p16.3 deletions, involving heterozygous NEUREXIN1 (NRXN1) deletion, dramatically increase the risk of developing neurodevelopmental disorders, including autism and schizophrenia.
|
31812984 |
2019 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
NRXN1 is highly expressed in brain and has been shown recently to be associated with ASD, schizophrenia, cognitive and behavioral abnormalities, and alcohol and nicotine dependence.
|
20162629 |
2010 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
NRXN1 copy number variation is a rare genetic factor commonly shared among autism spectrum disorder (ASD), schizophrenia, intellectual disability, epilepsy and developmental delay.
|
31759289 |
2019 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A number of genes that undergo radical changes in expression during this transition include candidates for schizophrenia (SZ), bipolar disorder (BD) and autism spectrum disorders (ASD) that function as transcription factors and chromatin modifiers, such as POU3F2 and ZNF804A, and genes coding for cell adhesion proteins implicated in these conditions including NRXN1 and NLGN1.
|
21915259 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
All of them affect multiple genes (apart from NRXN1) and cause substantial increases in risk to develop schizophrenia (odds ratios of 2 to over 50).
|
26130694 |
2015 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Among the genes disrupted by the remaining rare CNVs are MYT1L, CTNND2, NRXN1, and ASTN2, genes that play an important role in neuronal functioning but--except for NRXN1--have not been associated with schizophrenia before.
|
18940311 |
2008 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Chromosomal deletions of 1q21.1, 3q29, 15q13.3, 22q11.2, and NRXN1 and duplications of 15q11-q13 (maternal), 16p11, and 16p13.3 have the strongest association with schizophrenia.
|
22118685 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CNVs spanning the 2p16.3 (NRXN1) and the 15q11.2 gene rich region have been associated with severe neuropsychiatric disorders including schizophrenia.
|
26563496 |
2015 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
LHGDN |
Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.
|
17989066 |
2008 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.
|
17989066 |
2008 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Copy number variants (CNVs) and intragenic rearrangements of the NRXN1 (neurexin 1) gene are associated with a wide spectrum of developmental and neuropsychiatric disorders, including intellectual disability, speech delay, autism spectrum disorders (ASDs), hypotonia and schizophrenia.
|
22617343 |
2012 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Deletions at 2p16.3 involving exons of NRXN1 are associated with susceptibility for autism and schizophrenia, and similar deletions have been identified in individuals with developmental delay and dysmorphic features.
|
23495017 |
2013 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Eight recurrent CNVs have reproducibly been shown to increase the risk of schizophrenia by severalfold: 22q11.2(del), 15q13.3(del), 1q21(del), 1q21(dup), NRXN1(del), 3q29(del), 7q11.23(dup), and 16p11.2(dup).
|
30144930 |
2019 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia.
|
21827697 |
2011 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous copy-number variants and SNPs of CNTNAP2 and NRXN1, two distantly related members of the neurexin superfamily, have been repeatedly associated with a wide spectrum of neuropsychiatric disorders, such as developmental language disorders, autism spectrum disorders, epilepsy, and schizophrenia.
|
19896112 |
2009 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations of the NRXN1 gene, which encodes the presynaptic cell-adhesion molecule neurexin-1, were repeatedly associated with autism and schizophrenia.
|
26279266 |
2015 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, the manner in which NRXN1 gene variation may be related to brain morphology to confer risk for ASD or schizophrenia is unknown.
|
21687627 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, we did not find any association with age-at-onset of schizophrenia with NRXN1 polymorphisms.
|
21477380 |
2011 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In both human and mice, NRXN1 is co-expressed with numerous synaptic and cell signaling genes, and known schizophrenia candidates.
|
22832527 |
2011 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, NRXN1 deletions have been reported in schizophrenia, whereas CNTNAP2 variants are associated with several neuropsychiatric phenotypes.
|
20421335 |
2010 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Large NRXN1 deletions have also been associated with schizophrenia.
|
20860064 |
2010 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
MGD |
Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.
|
19822762 |
2009 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Mutation of the neurexin1-gene, NRXN1, interrupting the expression of neurexin1 has been associated with schizophrenia, autism, and intellectual disability.
|
22337556 |
2012 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Our findings link NRXN2 disruption to the pathogenesis of ASD for the first time and further strengthen the involvement of NRXN1 in SCZ, supporting the notion of a common genetic mechanism in these disorders.
|
21424692 |
2011 |